Cargando…
New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease
Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin3 (NT-3) bind to tyrosine kinase (Trk) receptors, TrkA, TrkB, and TrkC, respectively. This study investigated the efficacy of novel molecule agonists of Trk receptors in an in vivo model of dry eye disease (DED). Sm...
Autores principales: | Yu, Zhiyuan, Joy, Shaon, Mi, Tianxiong, Yazdanpanah, Ghasem, Burgess, Kevin, de Paiva, Cintia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453230/ https://www.ncbi.nlm.nih.gov/pubmed/36091713 http://dx.doi.org/10.3389/fmed.2022.937142 |
Ejemplares similares
-
Induction of Innate Inflammatory Pathways in the Corneal Epithelium in the Desiccating Stress Dry Eye Model
por: Yu, Zhiyuan, et al.
Publicado: (2023) -
IL-17 Producing Lymphocytes Cause Dry Eye and Corneal Disease With Aging in RXRα Mutant Mouse
por: Alam, Jehan, et al.
Publicado: (2022) -
Effects of Cathepsin S Inhibition in the Age-Related Dry Eye Phenotype
por: Galletti, Jeremias G., et al.
Publicado: (2023) -
Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
por: Mattila, Elina, et al.
Publicado: (2010) -
Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
por: Coursey, Terry G, et al.
Publicado: (2014)